Graphico

Graphico CapEx Growth

Delisted

The Year-over-Year CapEx Growth of Graphico (4930.T) as of Nov 14, 2026 is -64.40 %. In the previous year, Year-over-Year CapEx Growth was 89.14 % — a change of -172.24% (lower).

CapEx Growth

-64.40 %

YoY

-172.24%

Last updated:

Year-over-Year CapEx Growth of Graphico is 2023 -64.40 % . Year-over-Year CapEx Growth of Graphico was 2022 89.14 % . It decreases by -172.24% lower compared to the previous year.

The Graphico CapEx Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx Growth
Date
CapEx Growth
Jan 1, 2015
-78.87 JPY
Jan 1, 2018
204.77 JPY
Jan 1, 2019
-87.38 JPY
Jan 1, 2020
245.82 JPY
Jan 1, 2021
39.53 JPY
Jan 1, 2022
89.14 JPY
Jan 1, 2023
-64.40 JPY
The Graphico CapEx Growth history
YEARCapEx GrowthYoY
-64.40 %-172.24%
89.14 %+125.50%
39.53 %-83.92%
245.82 %-381.32%
-87.38 %-142.67%
204.77 %-359.64%
-78.87 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Graphico Stock analysis

What does Graphico do? Graphico Inc. generates revenue through the sale of health foods, cosmetics, ethical drugs, over-the-counter drugs, and household products via drug stores, general merchandise stores, home centers, variety stores, and mail-order channels. The company outsources manufacturing and logistics while focusing on product planning, development, marketing, and sales. Its main product categories include healthcare centered on health foods, beauty care centered on cosmetics, and ethical and over-the-counter drugs. Overseas sales are handled through country-specific distributors. The company targets consumers seeking health and beauty solutions through established retail channels and direct mail-order services. Product planning and development are central to its strategy, with a focus on health foods, cosmetics, and pharmaceuticals. The firm operates as a fabless business model, relying on external partners for manufacturing and logistics to maintain agility in product innovation. Graphico Inc. serves multiple segments including health-conscious women, beauty care consumers, and individuals seeking over-the-counter medications. Sales channels include drug stores, GMS, home centers, variety stores, and mail-order systems. The company's overseas presence is supported by distributors in each country, enabling global market access without direct operational infrastructure. Graphico is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Graphico stock

Year-over-Year CapEx Growth of Graphico is -64.40 % in 2023.

On Eulerpool you can find the complete historical development of Year-over-Year CapEx Growth Graphico since 2006 – with annual values, charts, and detailed analysis.

CapEx growth measures the percentage change in capital expenditures. Increasing CapEx can signal investment in future growth capacity.

To evaluate Year-over-Year CapEx Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year CapEx Growth.

Year-over-Year CapEx Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year CapEx Growth's Graphico historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Graphico

All Key Metrics — Graphico